C-19 vaccination booster programme – update

C-19 vaccination booster programme – update

September 15, 2021

Following on from the letter below setting out the early guidance on planning for the C-19 booster programme and seeking of EOI from pharmacies, the JCVI has now issued updated advice on C-19 booster vaccination.

The Joint Committee on Vaccination and Immunisation (JCVI) has updated its advice on the COVID-19 vaccine booster programme. In order to maintain the current high level of protection through the coming winter, the JCVI is advising that booster vaccines are offered to those more at risk from serious disease, and who were vaccinated during Phase 1 of the vaccine programme (i.e. priority groups 1 to 9). This includes those living in residential care homes for older adults, all adults aged 50 years or over, and frontline health and social care workers.

NHS England and NHS Improvement will shortly be communicating with those pharmacies that have been selected to take part in the booster programme to provide further information on the next steps for commencing this part of the overall COVID-19 vaccination programme.

Read more


NHSE&I publish details of C-19 vac booster programme

July 14, 2021

Following the publication by NHS England and NHS Improvement (NHSE&I) of a letter setting out early guidance for the NHS on planning for a COVID-19 vaccine booster programme – referred to as phase 3 of the vaccination programme – full information on how pharmacy contractors can apply to participate in the programme has now been published.

Today, NHSE&I have published the following documents:

Letter to all community pharmacy contractors

The Phase 3 Local Enhanced Service specification

Guidance on the Community Pharmacy Phase 3 Site Designation Process

The Phase 3 service specification seeks to implement interim advice from JCVI on the potential COVID-19 booster programme. This advice suggests the COVID-19 booster vaccines should be offered in two stages from September, starting with those most at risk from serious disease and that the seasonal flu vaccine should be offered alongside the third, booster dose of the COVID-19 vaccine.

The service specification for phase 3 is largely based on the current Local Enhanced Service specification for phases 1 and 2. Following a successful pilot of pharmacies administering lower volumes of vaccines, NHSE&I are now allowing contractors to express an interest in being commissioned to provide COVID-19 vaccines from a low capacity site (100 vaccination per week) in addition to the previous medium (350 vaccination per week) and large volume (1000 vaccination per week) site options.

Expressions of interest need to be submitted by 5pm on Wednesday 28th July 2021. Contractors already providing the COVID-19 vaccination service for phases 1 and 2 will also be required to express an interest in phase 3 following the same process.

NHSE&I webinar for contractors

NHSE&I are holding a webinar at 18:30 tomorrow (Thursday 15th July 2021) to share further details about the phase 3 arrangements.

Register for the webinar (now closed)




Posted in:


More Latest News >

PhAS 2022 webinar now on-demand

PSNC’s webinar on the updated 2022 Pharmacy Access Scheme (PhAS) is now available on-demand. Nearly 90% of attendees said they would...